Trial Search Results

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

This randomized clinical trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with newly diagnosed acute lymphoblastic leukemia that shows a decrease in or disappearance of signs and symptoms. Regular physical activity after receiving treatment for cancer may help to maintain a healthy weight and improve energy levels and overall health.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Children's Oncology Group

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):

Intervention(s):

  • Other: Educational Intervention
  • Other: Internet-Based Intervention
  • Other: Internet-Based Intervention
  • Other: Laboratory Biomarker Analysis
  • Device: Medical Device Usage and Evaluation
  • Other: Quality-of-Life Assessment
  • Other: Questionnaire Administration

Phase:

Phase 3

Eligibility


Inclusion Criteria:

   - All cancer cases with an International Classification of Diseases for Oncology (ICD)-O
   histologic behavior code of two "2" (carcinoma in situ) or three "3" (malignant), in
   remission

   - Patient must have completed curative therapy (surgery and/or radiation and/or
   chemotherapy) within the past 12 months at a Childrens Oncology Group (COG)
   institution

   - Patients must have a performance status corresponding to Eastern Cooperative Oncology
   Group (ECOG) scores of 0, 1, or 2; use Lansky for patients =< 16 years of age

   - At the time of consent, patient or parent/guardian reports less than 420 minutes of
   moderate to vigorous physical activity over the last week

   - Patient and at least one parent/guardian are able to read and write English, Spanish,
   and/or French; at least 1 parent/guardian must be able to read and write English,
   Spanish, and/or French in order to assist the patient with using their physical
   activity tracking device account

   - All patients and/or their parents or legal guardians must sign a written informed
   consent

   - All institutional, Food and Drug Administration (FDA), and National Cancer Institute
   (NCI) requirements for human studies must be met

Exclusion Criteria:

   - Patients with previous hematopoietic stem cell transplant (HSCT)

   - Patients with significant concurrent disease, illness, psychiatric disorder or social
   issue that would compromise patient safety or compliance with protocol therapy, or
   interfere with consent, study participation, follow up, or interpretation of study
   results

   - Female patients who are pregnant are not eligible; women of childbearing potential
   require a negative pregnancy test

   - Female patient who is postmenarcheal and has not agreed to use an effective
   contraceptive method (including abstinence) for the duration of study participation

   - Patients with a cognitive, motor, visual or auditory impairment that prevents computer
   use (e.g. unresolved posterior fossa syndrome) are not eligible

Ages Eligible for Study

8 Years - 16 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Christopher Nguyen Le
650-725-4318
Recruiting

Explore Related Trials

All Stanford Trials